The short answer
SEER reports a 68.6% five-year relative survival rate for leukemia overall. But 'leukemia' covers several very different diseases, from slow-growing chronic lymphocytic leukemia to fast-growing acute myeloid leukemia, and there is no standard stage system. The specific subtype matters far more than this blended number.
A survival statistic describes a large group diagnosed years ago — not a prediction for any one person.
The blended five-year relative survival rate across all leukemia types, diagnosed 2016–2022, was 68.6%.
'Leukemia' covers several very different diseases; your specific subtype matters far more than this blended number.
There is no standard localized/regional/distant staging system for leukemia, because it is already a disease of the blood and bone marrow.
Choose how you want to understand this
The full explanation.
Before you look at the numbers
Three things are true about the numbers below. Please read all three before you look at a single leukemia percentage.
First, a "5-year relative survival rate" for leukemia describes a large group of people. Those people were diagnosed with leukemia years ago. It is not a prediction about you. Everyone's leukemia, body, and treatment plan are different.
Second, this data lags behind today's care. These figures reflect people diagnosed with leukemia between 2016 and 2022. Targeted drugs for several leukemia subtypes have continued to be refined since then. So leukemia treatment today may already work better than these numbers suggest.
Third, an all-types leukemia number blends two very different groups. It mixes people with a slow-growing chronic leukemia and people with an aggressive acute leukemia. For leukemia, the subtype-specific detail below is almost always more useful than one blended average. And "5-year" is just a measuring window, not a leukemia milestone. It is not a life expectancy for anyone with leukemia. It is not a deadline either.
The SEER numbers for leukemia
SEER's most recent report covers people diagnosed with leukemia of any type between 2016 and 2022. Across all types combined, the five-year relative survival rate was 68.6%. That number is only a starting point. Leukemia is not one disease, and the major subtypes can have very different outlooks.
SEER explains that leukemia has no standard stage system. It is a cancer of the blood and bone marrow, not a solid tumor. Instead it is usually described as untreated, in remission, or recurrent, and sorted by subtype.
What "relative survival" actually means
Relative survival compares two groups. One group has leukemia. The other group is the same age and sex, but has no leukemia. Say the rate is 100%. That would mean the leukemia group was as likely to reach 5 years as the other. It is not the share of people who are free of leukemia. It is not the share of people who die from leukemia itself.
The four major leukemia types behave very differently. Chronic lymphocytic leukemia (CLL) often grows slowly and may not need immediate treatment. Chronic myeloid leukemia (CML) can often be well controlled for years with daily targeted pills. Acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL) grow quickly and usually need immediate, intensive treatment. Cancer Explained has a separate page for each subtype, with more detail. See the related links below.
What actually changes your outlook
A statistic describes a group. Your outlook depends on things specific to you.
- Leukemia subtype — acute or chronic, and lymphocytic or myeloid. There is no localized, regional or distant stage table for leukemia.
- Grade or risk category — how odd the cells look, and how quickly the leukemia tends to progress.
- Genetic and molecular features — the Philadelphia chromosome in CML, say, or FLT3 and NPM1 mutations in AML. These affect treatment and outlook.
- How your leukemia responds — early scans and labs often say more than the first numbers.
- Your overall health — other health problems, age, and fitness shape leukemia treatment and recovery.
- Access to care — a quick leukemia diagnosis, specialist care, and finishing treatment all matter.
Questions for your care team
- Which risk group does my leukemia fall into, and what is the five-year number for that group?
- Which biomarkers or molecular tests matter in leukemia, and were they run on my sample?
- How do my age and overall health change these leukemia statistics for me?
- Are there newer leukemia treatments available now that this data doesn't reflect yet?
- Beyond the general leukemia statistics, what does my team expect in my case?
- Where can I find support for how it feels to hear these leukemia numbers?
- What specific type and subtype of leukemia do I have, and were any genetic or molecular markers found?
If these numbers are hard to sit with
Leukemia numbers can leave you scared, numb, or overwhelmed. That is normal. It does not mean you are handling a leukemia diagnosis the wrong way. Many people take these leukemia numbers in slowly, or with someone in the room. Others skip the numbers until they feel ready. Cancer Anxiety and Uncertainty covers the fear these leukemia numbers can stir up. It is also worth telling your leukemia team how much detail you want, and when.
Sources
Words to know
Tap any term to see what it means.
Common questions
What does 68.6% five-year relative survival mean for leukemia?
It means that, on average, people diagnosed with any type of leukemia between 2016 and 2022 were about 68.6% as likely to be alive 5 years later as people of the same age and sex without leukemia. This blends very different leukemia types together, so it is only a starting point.
Why doesn't leukemia have a localized/regional/distant stage table like other cancers?
Leukemia is a cancer of blood-forming cells, which already circulate through the bloodstream and bone marrow. SEER notes there is no standard staging system for leukemia; instead, it is usually described as untreated, in remission, or recurrent, and classified by subtype rather than by how far it has spread.
Does this number predict what will happen to me?
No, and this is especially true for leukemia. The four major types (acute lymphoblastic, acute myeloid, chronic lymphocytic, and chronic myeloid leukemia) have very different courses and outlooks. Your specific subtype, genetic and molecular features, age, and treatment response matter far more than the blended statistic above.
Is this the most current data available?
It is the most recent SEER data available, but it still reflects people diagnosed between 2016 and 2022. Treatment for several leukemia subtypes, especially chronic myeloid leukemia and some forms of acute leukemia, has changed substantially in recent years with newer targeted drugs.
Questions to ask your doctor
Being prepared helps you get the most out of your appointments. Save or print these questions.
Tap a question to save it to your list (kept on this device).
Speak With Trained Specialists & Human Navigators
Cancer Explained provides educational guidance, but does not replace trained specialists, social workers, or your medical team.
Talk to a trained cancer information specialist
Free, confidential assistance from NCI Cancer Information Service via phone, chat, or email.
Contact your oncology team
Locate after-hours contact numbers, portal messages, or urgent triage phone lines.
Find a patient navigator
Get one-on-one help with appointments, logistics, translation, and care coordination.
Find a genetic counselor
Discuss inherited mutation risk, family history, and genetic testing options.
Find an oncology social worker
Access emotional counseling, family support groups, and mental health resources.
Find a financial navigator
Locate copay assistance foundations, grant programs, and lodging/travel support.
Find a clinical-trial specialist
Search matching studies and speak with NCI trial information specialists.
Get urgent help
Immediate emergency guidance for fever (>100.4°F during chemo), severe pain, or shortness of breath.
Help Us Improve This Guide
Did this explanation answer your question and help you determine your next step?
Know someone who needs this?
Plenty of people are looking for something like this and do not know where to start. If this would help a friend or someone you love, send it on — we have written an opening line so you do not have to stare at an empty message. You can change every word of it.
Your message is written and sent in your own email or messaging app — we never see who you send it to, and nothing is added to any list.
Plain-language explanation of the published sources cited on this page. AI-assisted, source-checked, not clinician-reviewed.
Last updated: 2026-08-18Next planned review: 2027-08-03
How this page was created
Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes. We do not employ clinicians and do not intend to — our work is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.
Editorial status — Source checked. This page was written with AI assistance and checked line by line against the sources listed on it. That confirms the sources support what the page says. It is not a medical review, and it does not confirm the page is complete or right for your situation.
High-risk topic — talk to your care team. This topic can involve urgent, individual medical decisions. This page is general education only: it cannot tell you whether your situation is an emergency or what you personally should do. Follow your oncology team's instructions and contact them for individual guidance.
Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.
How this page was created
Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes. We do not employ clinicians and do not intend to — our work is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.
Editorial status: Source checked — This page was written with AI assistance and checked line by line against the sources listed on it. That confirms the sources support what the page says. It is not a medical review, and it does not confirm the page is complete or right for your situation.
Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.
Read more about our editorial process, our use of AI, and our corrections policy.
Spotted a problem? Report an error — a factual mistake, broken or outdated source, confusing wording, or anything that seems unsafe. Please do not include names, medical record numbers, dates of birth, addresses, or other identifying medical information in your report.
After using this page, do you understand what to do next?
Anonymous — we only record the answer, never who gave it.
Related articles
Still have questions?
Educational answers, plain language
Free to print and share